Skip to main content
Antonio Carlos Arrieta

Antonio Carlos Arrieta

•Clinical Professor, Pediatrics, UC Irvine School of Medicine
•Director Pediatric Infectious Diseases, CHOC Children's Hospital

Biography

Antonio Carlos Arrieta, M.D., is Clinical Professor of Pediatrics at UC Irvine School of Medicine and Director of Pediatric Infectious Diseases and Director of Infectious Diseases Clinical Research at CHOC Children's Hospital in Orange, California. He received his medical degree from Universidad Peruana Cayetano Heredia in Lima, Peru, and completed his fellowship in Pediatric Infectious Diseases at Memorial Miller Children's Hospital/University of California, Irvine. From January 2014 to December 2016, he served as President of the CHOC Medical Staff.

Arrieta has served as principal investigator on more than 100 clinical trials evaluating antimicrobial agents, antifungal therapies, and vaccines in pediatric populations. His research has focused on invasive fungal infections in immunocompromised children, pneumococcal disease surveillance following vaccine implementation, and the pharmacokinetics of antimicrobial agents in neonates and infants. He has been principal investigator for multiple Phase 1, 2, and 3 trials of agents including micafungin, voriconazole, isavuconazonium sulfate, ceftolozane/tazobactam, and daptomycin in pediatric patients. His investigator-initiated studies have examined the epidemiology of invasive pneumococcal disease in Orange County following introduction of pneumococcal conjugate vaccines and the use of biomarkers for diagnosis of serious bacterial infections in young infants.

Arrieta is a Fellow of the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society. He has served on multiple guideline development panels for the Infectious Diseases Society of America, including the 2021 Guideline on Diagnosis and Management of Acute Hematogenous Osteomyelitis in Pediatrics and the 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics. From October 2013 to November 2015, he served as a member of the Anti-Infective Drugs Advisory Committee for the Food and Drug Administration, and since November 2016 has served as an ad hoc consultant to the Antimicrobial Drugs Advisory Committee. He currently serves as Associate Editor for the journals Children and Frontiers in Pediatrics and is a panel member for the PIDS/IDSA Aspergillosis Guidelines and the IDSA Clinical Practice Guidelines for Septic Arthritis.

Return to top

Education

  • MD, Universidad Peruana Cayetano Heredia, 1985
  • Residency in Pediatrics, Southern Illinois University
  • Fellowship in Pediatric Infectious Diseases, Memorial Miller Children's Hospital/University of California
Return to top

Distinctions

  • Member of the Anti-Infective Drugs Advisory Committee for the Food and Drug Administration, 2013-2015
  • Ad hoc consultant to the Antimicrobial Drugs Advisory Committee, 2016
  • Fellow of the Infectious Diseases Society (FIDSA), 2012
  • Fellow of the Pediatric Infectious Diseases Society (FPIDS), 2021
  • Member Fellowship Award Committee for the Pediatric Infectious Diseases Society, 2023-2026
  • Member of the Publication Committee for the Pediatric Infectious Diseases Society, 2012-2015
  • CHOC Children's Residency Program Teacher of the Year Award, 1993-1994, 1995-1996, 1997-1998, 2003-2004, 2017-2018
  • CHOC Children's Outstanding Teacher Award, 1994-1995, 1998-1999, 2014
  • OCMA Physician of Excellence Award, 2005-2025
  • Best Doctors in Orange County, 2001-2006
Return to top

Areas of Expertise

  • Pediatric Infectious Diseases
  • Invasive Pneumococcal Disease
  • Antifungal Therapy
  • Candidemia Treatment
  • Urinary Tract Infections
  • COVID-19 Convalescent Plasma
  • Antimicrobial Pharmacokinetics

Recent Publications

Return to top

Most Cited Publications

Return to top

Contact Information

Email: arrietaa@uci.edu

Phone: (714) 509-8403

Address: 1201 W. LaVeta Avenue, Orange, CA 92868, Irvine, CA 92868

Return to top

This profile was created with the help of AI.

Last updated on 3/11/2026.